Join Implantica's Q3 2024 Presentation: What to Expect
Implantica AG (publ) creatively engages its investors with an invitation to join their informative presentation for the third quarter of 2024. This event, set to take place on November 15 at 15:00 CET, is a golden opportunity for stakeholders to delve into the company’s progress and innovations. The interim report for the third quarter will be unveiled earlier the same morning at 8:00 a.m. CET, setting the stage for a comprehensive overview of Implantica's performance.
Participating in the Presentation
For those interested in being part of the discussion, the presentation will be conducted in English and accessible via an audiocast accompanied by a teleconference. This multi-channel approach aims to facilitate maximum participation.
Webcast Participation
To engage through the webcast, attendees will find the link made readily available for smooth access. This method not only guarantees clarity but also can reach a larger audience, ensuring that every interested party can stay updated on the latest developments.
Teleconference Registration
For those preferring a more direct involvement, registration for the teleconference is crucial. Once registered, participants will receive necessary details, including the phone number and conference ID. This setup allows for a seamless experience, putting attendees directly in touch with the company’s leaders.
Featured Speakers
Leading the conversation will be a panel of esteemed individuals from Implantica. CEO Peter Forsell will share strategic updates, while CFO Andreas Öhrnberg will provide insights into the financials. Chief Corporate Affairs Officer Nicole Pehrsson will also be present to discuss the company’s vision and direction.
Contact Information
Should attendees have further inquiries, they are encouraged to reach out to Nicole Pehrsson in Investor Relations. With her availability via telephone, stakeholder questions can be promptly addressed, enhancing communication between the company and its investors.
Company Overview
Implantica is not just another name in the medical technology industry; it is a pioneering entity devoted to integrating advanced technologies directly into patient care. At the forefront of their offerings is the RefluxStop™, a CE-marked implant that promises to revolutionize the approach to gastroesophageal reflux treatment. Supported by successful clinical trials, this innovation holds the potential to fundamentally change how anti-reflux treatment is administered.
Moreover, Implantica emphasizes the importance of eHealth, focusing on developing a broad, patent-protected pipeline. Their unique approach encompasses two platform technologies: one designed to monitor health parameters and facilitate remote communication with caregivers, and another that powers implants wirelessly through intact skin.
Conclusion
As Implantica continues to make strides in healthcare technology, the upcoming presentation provides a vital opportunity for investors and interested parties to learn more about the company's innovative solutions and future endeavors. Stand by as they present their quarterly results and future directives that aim to shape the industry.
Frequently Asked Questions
What is the date and time of the Implantica Q3 2024 presentation?
The presentation will be held on November 15 at 15:00 CET.
How can I participate in the Implantica presentation?
You can join via webcast or teleconference by registering beforehand.
Who will be speaking during the presentation?
The speakers will include CEO Peter Forsell, CFO Andreas Öhrnberg, and Chief Corporate Affairs Officer Nicole Pehrsson.
What product is Implantica known for?
Implantica's lead product is the RefluxStop™, which aims to prevent gastroesophageal reflux.
How can I contact Investor Relations at Implantica?
You can contact Nicole Pehrsson, the Investor Relations representative, via phone.
